Ota S - Search Results

1

[A modified administrated schedule for combination therapy with irinotecan and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical cancer--a report of 2 cases as a pilot study].

Kumagai S, Fujiyoshi K, Sugiyama T, Ota S, Yoshimura O, Nishida T, Kamura T. Kumagai S, et al. Among authors: ota s. Gan To Kagaku Ryoho. 2001 May;28(5):701-5. Gan To Kagaku Ryoho. 2001. PMID: 11383222 Japanese.

2

Remission of metastatic cervical adenocarcinoma with weekly paclitaxel.

Ota S, Sugiyama T, Ushijima K, Fujiyoshi K, Komai K, Hirai N, Nishida T, Kamura T. Ota S, et al. Int J Gynecol Cancer. 2001 Mar-Apr;11(2):167-8. doi: 10.1046/j.1525-1438.2001.011002167.x. Int J Gynecol Cancer. 2001. PMID: 11328417

3

Weekly 1 hour paclitaxel infusion in patients with recurrent gynecological tumors: a pilot study.

Ota S, Sugiyama T, Komai K, Hirai N, Kumagai S, Ushijima K, Nishida T, Kamura T. Ota S, et al. Jpn J Clin Oncol. 2001 Aug;31(8):395-8. doi: 10.1093/jjco/hye077. Jpn J Clin Oncol. 2001. PMID: 11574633 Clinical Trial.

4

A carcinoma in situ arising in an endocervical polyp--a case report.

Nishida T, Sugiyama T, Miyoshi T, Kataoka A, Kumagai S, Ota S, Iwanaga S, Yakushiji M. Nishida T, et al. Among authors: ota s. Kurume Med J. 1994;41(1):37-40. doi: 10.2739/kurumemedj.41.37. Kurume Med J. 1994. PMID: 7933916 Free article.

5

Successful treatment of two patients with recurrent endometrial cancer by weekly paclitaxel.

Ota S, Sugiyama T, Ushijima K, Komai K, Fujiyoshi K, Hirai N, Nishida T, Kamura T. Ota S, et al. Cancer Lett. 2000 Nov 10;160(1):9-12. doi: 10.1016/s0304-3835(00)00548-6. Cancer Lett. 2000. PMID: 11098078

6

An unusual endometrioid adenofibroma of the uterine cervix: a histologic and immunohistochemical study.

Nishida T, Sugiyama T, Ushijima K, Kataoka A, Fujiyoshi K, Tanaka H, Ota S, Iwanaga S, Yakushiji M. Nishida T, et al. Among authors: ota s. Int J Gynecol Cancer. 1995 May;5(3):236-239. doi: 10.1046/j.1525-1438.1995.05030236.x. Int J Gynecol Cancer. 1995. PMID: 11578483

7

[A trial of biweekly paclitaxel administration in consideration of QOL for advanced or recurrent gynecologic cancer].

Fushiki H, Yoshimoto H, Ikoma T, Ota S. Fushiki H, et al. Among authors: ota s. Gan To Kagaku Ryoho. 2005 May;32(5):691-3. Gan To Kagaku Ryoho. 2005. PMID: 15918575 Clinical Trial. Japanese.

8

Ovarian hepatoid carcinoma without staining for alpha-fetoprotein in the primary site.

Nishida T, Sugiyama T, Kataoka A, Ushijima K, Ota S, Iwanaga S, Yakushiji M. Nishida T, et al. Among authors: ota s. Int J Gynecol Cancer. 1995 Jul;5(4):314-318. doi: 10.1046/j.1525-1438.1995.05040314.x. Int J Gynecol Cancer. 1995. PMID: 11578497

9

In-vitro cytotoxicity in ovarian-cancer of low-dose continuous exposure to microtubule inhibitors (Paclitaxel taxotere) combined with Cisplatin.

Kiyozuka Y, Nishimura H, Nakashima A, Imamura K, Ota S, Yakushiji M, Imai S, Morimatsu M. Kiyozuka Y, et al. Among authors: ota s. Oncol Rep. 1995 Jul;2(4):517-23. doi: 10.3892/or.2.4.517. Oncol Rep. 1995. PMID: 21597768

10

Expression of matrix metalloproteinase-2 (mmp-2) in cervical neoplasia - immunohistochemical and in-situ hybridization studies.

Ota S, Miyajima Y, Nakashima A, Morimatsu M, Yakushiji M. Ota S, et al. Int J Oncol. 1994 Dec;5(6):1301-4. doi: 10.3892/ijo.5.6.1301. Int J Oncol. 1994. PMID: 21559713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,644 results

Search Page

Filters